Generics 16

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Naloxone manufacturers

16 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

16 products found

buprenorphine + naloxone

Tablets, sublingual 2mg+0.5mg, 4mg+1mg, 8mg+2mg, 12mg+3mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #9258
This company is a research-driven pharmaceutical manufacturer specializing in oral solid dosage forms. They offer both pharmaceutical and nutraceutical products, including pre-formulation intermediates like granules and pellets, as well as finished formulations such as tablets, capsules, and oral thin films. Their focus is on developing differentiated generic products using innovative process technologies to enhance patient convenience and affordability. Key therapy areas include urology, cardiovascular health, infectious diseases, gastrointestinal disorders, pain management, vitamins, and skin conditions. The company holds EU-GMP certifications alongside WHO-GMP, ISO 9001, and NSF/ANSI 455-2 certifications. They operate with a robust R&D center recognized by the Indian government and collaborate with pharmaceutical companies globally for product development and marketing.

Manufacturer usually replies in 4 days

naloxone

Vials, injection 0.4 mg/ml - 1 ml, 10 ml

Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA
Comments
ANDA / R &D Status: ANDA to be filed in Q2-2023, approval expected Q2-2024; US RLD / Holder: "Narcan / Adapt"; Indication: Opioid antagonist;
Manufacturer #8216
This fast-growing pharmaceutical company boasts a dominant presence in Latin America, Francophone Africa, and a growing footprint in regulated markets like the EU and North America. Founded in 1990, it initially focused on ointments and creams before expanding its product range significantly. With over 4,000 global product licenses, they cater primarily to the "Bottom of the Pyramid" through their owned distribution networks. The company's manufacturing facility holds multiple certifications including US FDA approval (with three successful inspections since 2016), EU-GMP, ANVISA-Brazil, INVIMA-Colombia, and COFEPRIS-Mexico. They prioritize innovation with a significant portion of their earnings invested in research and development of safe and effective products across various dosage forms. Key therapy areas are not specified.

Manufacturer usually replies in 6 days

naloxone

Injection 200 mcg, 400 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #28571

This vertically integrated pharmaceutical company specializes in developing, manufacturing, and marketing a wide range of products across multiple therapeutic areas. Their key focus areas include oncology, blood-related products, nephrology, cardiology, gynecology, diabetology, and beta-lactam cephalosporins, along with vitamins and minerals. They also offer nutraceuticals and herbal products. The company's product portfolio encompasses various dosage forms such as injectables, suppositories, tablets, capsules, suspensions, syrups, ointments, emulsions, elixirs, ophthalmics, effervescent tablets, and dry powder. They have a strong global presence, participating in prominent industry events across regions like Europe and the Middle East. The company prioritizes quality and adheres to GMP certifications, further bolstering their commitment to delivering reliable pharmaceutical solutions.

Manufacturer usually replies in 1 days

Want to see all 16 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Buprenorphine Manufacturers

Buprenorphine is an opioid which is used to treat chronic pain, and acute pain in the body. Normally Buprenorphine can be used under the tongue, by injection, or as a skin patch. The first use of this medicine is to treat moderate to severe pain. Buprenorphine belongs to a special class of drugs called opioid agonist-antagonists. Simultaneously, this medicine is given to those people who have addiction and they want to get out of addiction. This medicine is used to cure substance abuse. Some problems may occur with an over dose of Buprenorphine such as headache, fainting, drowsiness, fatigue, headache, hyperhidrosis, vomiting, nausea, dizziness, sweating, fever, xerostomia, irregular heartbeat and breathing. Difficulty may be experienced. If you are allergic to doing this, then you should immediately visit the doctor. Buprenorphine is a partial opioid agonist. At low to moderate doses, it causes euphoria or respiratory depression. However, the effects of buprenorphine are milder than those of complete opioid agonists such as methadone and heroin. Buprenorphine is both safe and effective when used as directed. Buprenorphine is a powerful opioid pain reliever. It is used to relieve extreme pain, such as during or after a surgery, a serious injury, or cancer pain. It's also used to treat various sorts of pain that have been bothering you for a long time, after milder painkillers have ceased functioning. Buprenorphine treats withdrawal symptoms and can eliminate cravings more safely than other medications. Once you've found the proper dose of buprenorphine, it can help you stop taking other opioids, whether prescribed or acquired. It is entirely up to you how long you stay on buprenorphine. However, if you progressively taper off buprenorphine once your life becomes more stable and you haven't used non-prescribed opioids for at least six months, you are considerably less likely to relapse. Weight gain or decrease have not been noted as negative effects in Suboxone research. Suboxone users, on the other hand, have experienced weight gain. Buprenorphine should be started 12 to 24 hours after using a short-acting opioid and 24 to 48 hours after using a long-acting opioid. The majority of patients should take buprenorphine/naloxone combo pills.

How does Buprenorphine work?

Buprenorphine mainly works in two ways. First, it displaces other opioids from receptors that are present in the brain. Other than that, it binds to these same receptors so that other opioids do not overpower them. People who use buprenorphine do not experience strong cravings for other opioids. Dosage - Buprenorphine is used as a tablet, transdermal film, and injectable. The doctor advises you to take the medicine according to your level of need. The dosage in adults for drug addiction is 8 mg on the first day and 16 mg on the next day. So before using you should always take advice from a doctor.

The Cost of Buprenorphine

An online search for the wholesale price for sale of Buprenorphine for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. The price of this medicine is different in different pharmacy companies. Well a pack of 30 tablets costs $25 which is 8 mg. Where you have to pay $50 for 60 tablets. These prices are only for those customers who pay in cash and are not valid with insurance plans.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Buprenorphine distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Buprenorphine suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Buprenorphine. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Buprenorphine is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturer's Buprenorphine suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Buprenorphine Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible